BioXtreme Ltd. news

BioXtreme is proud to announce a new cooperation agreement was recently signed with Advanced Medical Solutions s.r.o (AMS) from Brno, Czech Republic. The agreement situates AMS as BioXtreme’s representative in the Czech Republic and Slovakia, with exclusive distribution rights for BioXtreme’s neurorehabilitation products and forming connections with hospitals and rehabilitation centres around the two countries.

BioXtreme has developed a ground-breaking robotic device for m

BioXtreme is proud to announce that a new commercial evaluation agreement was signed with STEPS Budapest Center for Robotic Rehabilitation. The agreement includes a 6- months evaluation period for deXtreme, by the end of which STEPS commits to purchasing the device (pending evaluation criteria are met).

BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurol

Villa Beretta Rehabilitation Center and BioXtreme are proud to announce that they have agreed to conduct a joint evaluation project in the hospital’s facility in Costa-Masnaga, Italy.

BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Villa Beretta is world known rehabilitation center in Italy with a cuttingedge R&D department.

Reuth Rehabilitation Hospital and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the hospital’s facility in Tel-Aviv, Israel.

BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Reuth is one of the biggest rehabilitation hospitals in Israel with a cutting-edge R&D depa

University Hospitals Leuven, KU Leuven and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the university’s facility in Leuven, Belgium.

BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Leuven hosts one of the biggest rehabilitation departments in Belgium with a cutting-

BioXtreme is happy to announce a new addition to its management team – Mrs. Tamar Moyal. Tamar will serve as the company’s Sales Manager and will be in charge of establishing sales operations in North America and Europe, including business development, contact with distributors, KOL’s, developing training materials and more.

Tamar has more than 30 years of experience in sales management, business development, clinical training and training development particularly in

BioXtreme is proud to announce that, following our ISO-13485 certification from the Israeli Standards Institution (www.sii.org.il), it has received its CE Marking, based on self declaration.

The CE Marking is intended for deXtreme, our upper limb neurorehabiliatation robotic device, meant to treat stroke and other TBI patients with our novel Error Enhancement technology. By this CE Marking we declare that deXtreme is compliant with EU standards for health, safety, and environmental pr

We are proud to announce that BioXtreme has formed a strategic partnership with Jamzone. Located in the Netherlands, Jamzone is an innovation lab, specializing in development of innovative products and services that are cutting-edge in mental, emotional and behavioral healthcare and performance.

The first phase of the partnership will focus on the VR and AR environments of deXtreme™ and user interface, and will include a mutual develo

We are proud to announce that BioXtreme was awarded a R&D grant from the Israel Innovation Authority (coupled with additional investment from our strategic investor) in the amount of $1M.

The grant will be used to further develop and improve our groundbreaking solution, deXtreme, as well as develop a future finger grip product (either as a complementary product for deXtreme or an autonomous product).

This grant is yet another vote of confidence and acknowledgment to our